药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methyprylon
Bleselumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Bleselumab.
Methyprylon
Rozanolixizumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Rozanolixizumab.
Methyprylon
Risankizumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Risankizumab.
Methyprylon
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Belinostat is combined with Monomethyl fumarate.
Methyprylon
Tetrandrine
The risk or severity of adverse effects can be increased when Belinostat is combined with Tetrandrine.
Methyprylon
Fluclorolone
The risk or severity of adverse effects can be increased when Belinostat is combined with Fluclorolone.
Methyprylon
Fluperolone
The risk or severity of adverse effects can be increased when Belinostat is combined with Fluperolone.
Methyprylon
Begelomab
The risk or severity of adverse effects can be increased when Belinostat is combined with Begelomab.
Methyprylon
Fluocortin
The risk or severity of adverse effects can be increased when Belinostat is combined with Fluocortin.
Methyprylon
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Belinostat is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Methyprylon
Hypericin
The risk or severity of adverse effects can be increased when Belinostat is combined with Hypericin.
Methyprylon
Acteoside
The risk or severity of adverse effects can be increased when Belinostat is combined with Acteoside.
Methyprylon
Deoxyspergualin
The risk or severity of adverse effects can be increased when Belinostat is combined with Deoxyspergualin.
Methyprylon
Doxifluridine
The risk or severity of adverse effects can be increased when Belinostat is combined with Doxifluridine.
Methyprylon
Trofosfamide
The risk or severity of adverse effects can be increased when Belinostat is combined with Trofosfamide.
Methyprylon
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Belinostat is combined with Cepeginterferon alfa-2B.
Methyprylon
Gusperimus
The risk or severity of adverse effects can be increased when Belinostat is combined with Gusperimus.
Methyprylon
Mizoribine
The risk or severity of adverse effects can be increased when Belinostat is combined with Mizoribine.
Methyprylon
Ozanimod
The risk or severity of adverse effects can be increased when Belinostat is combined with Ozanimod.
Methyprylon
Triptolide
The risk or severity of adverse effects can be increased when Belinostat is combined with Triptolide.